List of authors for the Japanese Urological Association guidelines Japanese edition published in 2008: Akihiko Okuyama, Seiji Naito, Tomoaki Imamura, Hideo Yasunaga, Hideyuki Akaza, Shiro Hinotsu, Yoichi Arai, Yoshiyuki Kakehi, Takushi Dokiya, Shin Egawa, Kazuhiro Suzuki, Hirofumi Koga, Naoya Masumori, Koichiro Akakura, Kiyotaka Kawashima, Koji Okihara, Kazuto Ito.
Guidelines
Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
Article first published online: 8 SEP 2008
DOI: 10.1111/j.1442-2042.2008.02125.x
© 2008 The Japanese Urological Association
Additional Information
How to Cite
Ito, K., Kakehi, Y., Naito, S., Okuyama, A. and Japanese Urological Association (2008), Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan. International Journal of Urology, 15: 763–768. doi: 10.1111/j.1442-2042.2008.02125.x
- §
List of authors for the Japanese Urological Association guidelines Japanese edition published in 2008: Akihiko Okuyama, Seiji Naito, Tomoaki Imamura, Hideo Yasunaga, Hideyuki Akaza, Shiro Hinotsu, Yoichi Arai, Yoshiyuki Kakehi, Takushi Dokiya, Shin Egawa, Kazuhiro Suzuki, Hirofumi Koga, Naoya Masumori, Koichiro Akakura, Kiyotaka Kawashima, Koji Okihara, Kazuto Ito.
- †
Secretary of the Japanese Urological Association.
- ‡
President of the Japanese Urological Association.
Publication History
- Issue published online: 8 SEP 2008
- Article first published online: 8 SEP 2008
- Received 13 May 2008; accepted 2 June 2008.
- Abstract
- Article
- References
- Cited By
The exposure rate of screening for prostate cancer using prostate-specific antigen (PSA) in Japan is still very low compared with that in the USA or Western Europe. The mortality rate of prostate cancer will increase in the future and in 2020 it will be 2.8 times higher than in 2000. Therefore, there is an urgent need to determine the best available countermeasures to decrease the rate of prostate cancer death.

1442-2042/asset/olbannerleft.gif?v=1&s=32187154acf30aa10428a92beffa429b844f9096)
